| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 2 | |
| #2 | Australia | 1 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | Chile | 1 | |
| #6 | Colombia | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Singapore | 1 | |
| #10 | United States | 1 | |
| #11 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | He Xiaowen | 10 |
| #2 | Wang Huajing | 9 |
| #3 | Li Bohua | 7 |
| #4 | Guo Hao | 3 |
| #5 | Ling Youguo | 3 |
| #6 | Li Huijiao | 3 |
| #7 | Yang Huanfeng | 3 |
| #8 | Ying Bi | 2 |
| #9 | Ma Haili | 2 |
| #10 | Huajing Wang | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021057932A1 | Modified immune cell and use thereof | |
| CA3095498A1 | Anti-pd-l1 antibody and use thereof |